97028 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans Receptors; Cell surface antigens; Cell surface determinants
Methods and compositions for modulating Toso activity
#2402Gene expression control DNA element and associated protein
#2403Method of treating asthma or reducing inflammatory cell lung inflammation by administering toll-like receptor 3 antibodies
#2404Directed Engagement Of Activating Fc Receptors
#2405Method of treating type 1 diabetes by administering NKp46 polypeptide
#2406Identification of tumor-associated cell surface antigens for diagnosis and therapy
#2407Compositions and methods for promoting wound healing and tissue regeneration
#2408Antigen-specific T cell receptors and T cell epitopes
#2409Dendritic cell marker and uses thereof
#2410Peptides for generating an antibody selectively binding to a non-ATP-binding P2X7 receptor but not to an ATP-binding P2X7 receptor
#2411Compounds and therapeutic applications related to inhibition of dendritic cell immunoreceptor (DCIR) activity and signaling events
#2412Albumin Fusion Proteins
#2413Modified polynucleotides for the production of biologics and proteins associated with human disease
#2414Modified polynucleotides for the production of secreted proteins
#2415AAV-mediated subcellular targeting of heterologous rhodopsins in retinal ganglion cells
#2416Peptides of syndecan-1 for inhibit angiogenesis
#2417Compositions and methods for treating antiphospholipid syndrome
#2418VEGF-activated trail ligands
#2419Vesicular stomatitis viruses
#2420G PROTEIN COUPLED RECEPTORS AND USES THEREOF
#2421Antibodies to non-functional P2Xreceptor
#2422Polynucleotides encoding Toll-Like Receptor 3 antagonists
#2423Cancer-associated antigen
#2424Human ULIP/CRMP protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes
#2425Modified human tumor necrosis factor receptor-I polypeptide or fragment thereof, and method for preparing same
#2426HEMOKININ-1 RECEPTOR AND HEMOKININ-1-DERIVED PEPTIDE
#2427IMMUNOGENIC VACCINE
#2428Template-fixed peptidomimetics with CXCR7 modulating activity
#2429Peptides based on the transmembrane domain of a toll-like receptor (TLR) for treatment of TLR-mediated diseases
#2430Vaccines comprising mutant GPCRs with increased conformational stability relative to parent receptors
#2431Inhibitors of Bcl-2
#2432Moesin fragments and uses thereof
#2433Anti-Tie2 antibodies and uses thereof
#2434DC-STAMP antibodies
#2435Inhibitors of TLR signaling by targeting TIR domain interfaces
#2436Activatable toxin complexes comprising a cleavable inhibitory peptide
#2437Method and composition for crystallizing G protein-coupled receptors
#2438Mannose receptor C type 1 (MRC1) codon optimized cell line and uses thereof
#2439Fusion protein for antagonizing angiogenesis inducible factors and uses thereof
#2440Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T-cells
#2441Nucleic acids encoding T2R bitter taste receptors
#2442ANTIBODIES WITH T-CELL RECEPTOR LIKE SPECIFICITY TOWARDS NATIVE COMPLEXES OF MHC CLASS II AND DIABETES-ASSOCIATED AUTOANTIGENIC PEPTIDES
#2443COLON AND PANCREAS CANCER SPECIFIC ANTIGENS AND ANTIBODIES
#2444Inhibition of AXL/GAS6 signaling in the treatment of liver fibrosis
#2445Light-activated cation channel and uses thereof
#2446Variants derived from ActRIIB
#2447Material for screening for compound acting on ion channel and use thereof
#2448Protein binding domains stabilizing functional conformational states of GPCRs and uses thereof
#2449BIOMARKER FOR DIAGNOSING CANCER AND METHOD OF ISOLATING CANCER CELL USING THE SAME
#2450Anti-human folate receptor beta antibodies and methods of use
#2451Na+/Mg2+ Exchanger
#2452T1R taste receptors and genes encoding same
#2453NOGO Receptor-Mediated Blockade of Axonal Growth
#2454Antibodies directed to the receptor tyrosine kinase c-Met
#2455Endogenous and Non-Endogenous Versions of Human G Protein-Coupled Receptors
#2456Parstatin peptides
#2457Human T2R nucleic acid sequences
#2458Antagonist anti-Notch3 antibodies and their use in the prevention and treatment of Notch3-related diseases
#2459Peptides as active agents to stabilize biological barriers
#2460Variants of human taste receptor genes
#2461METHODS AND COMPOSITIONS FOR MANIPULATING THE GUIDED NAVIGATION OF ENDOTHELIAL TUBES DURING ANGIOGENESIS
#2462Nucleic acids molecule encoding the polypeptide for treating virus-induced cancer
#2463Method of producing the polypeptide for treating virus-induced cancer
#2464Method for expressing a mouse olfactory receptor Olfr15 on a cell membrane
#2465Tumor Marker and Methods of Use Thereof
#2466Soluble tandem selectin glycoprotein ligand molecules
#2467Molecular signature of cancer
#2468Epitopes of the human PDGF receptor able to bind human auto-antibodies, antibodies and uses thereof
#2469Conjugates of surface proteins as malaria vaccines
#2470Microorganisms for imaging and/or treatment of tumors
#2471Tango 240 nucleic acids and uses thereof
#2472NOVEL VACCINE THAT TARGETS TUMOR VESSELS AS AN EFFICIENT TOOL IN TUMOR THERAPY
#2473Novel Hemopoietin Receptor Protein, NR10
#2474T-cell receptor and nucleic acid encoding the receptor
#2475Etanercept formulations stabilized with metal ions
#2476Etanercept formulations stabilized with amino acids
#2477Sperm-specific cation channel, CatSper1 and uses therefor
#2478MODULATORS AND MODULATION OF THE INTERACTION BETWEEN RGM AND NEOGENIN
#2479MEDIUM, DEVICES AND METHODS
#2480Tools for the identification of Lingo-1, Lingo-2, Lingo-3 and Lingo-4 ligands, and uses thereof
#2481Multimeric Fc receptor polypeptides
#2482ISOFORMS OF THE HUMAN SST5 RECEPTOR ORIGINATED BY ALTERNATIVE SPLICING AND OLIGONUCLEOTIDE PAIRS TO DETECT THEM BY PCR
#2483METHODS OF TREATING LIVER CONDITIONS USING NOTCH2 ANTAGONISTS
#2484Method of identifying transmembrane protein-interacting compounds
#2485METHOD OF QUANTIFYING RECOVERY RATE OF EXOSOME
#2486Sperm-specific cation channel, CATSPER3, and uses therefor
#2487Sperm-specific cation channel, CatSper4, and uses therefor
#2488cDNA-derived nucleic acids encoding red-shifted channelrhodopsins
#2489Composition and methods for reducing opioid-induced pruritus
#2490Fn 14/TRAIL Fusion Proteins
#2491ACTRIIB-FC polynucleotides, polypeptides, and compositions
#2492Methods for detection of botulinum neurotoxin
#2493Method for producing cAMP using chimeric olfactory receptor
#2494Detection of human T1R expressing cells
#2495TREATMENT OF NEUROLOGICAL OR NEURODEGENERATIVE DISORDERS
#2496High affinity NY-ESO T cell receptors
#2497METHOD AND SYSTEM FOR MAPPING SYNAPTIC CONNECTIVITY USING LIGHT MICROSCOPY
#2498Composition For Delivery Of Genetic Material
#2499Methods of inhibiting photoreceptor apoptosis by eliciting the Faim2 antiapoptotic pathway
#2500Inhibitors of mitochondrial fission and methods of use thereof
#2501IDENTIFICATION OF A PEPTIDE(S) THAT INDUCES AUTOIMMUNE ANTERIOR UVEITIS
#2502Pro-angiogenic fragments of prominin-1 and uses thereof
#2503MODIFIED ADAM DISINTEGRIN DOMAIN POLYPEPTIDES AND USES THEREOF
#2504CATION CHANNEL ACTIVITY
#2505HUMAN SWEET TASTE RECEPTOR-ACTING SWEET TASTE REGULATING SUBSTANCE TO SWEET TASTE SUBSTANCE
#2506ANTIBODIES THAT BIND TO PSCA PROTEINS FOR DIAGNOSIS OF CANCER
#2507Glycosylated specificity exchangers
#2508LTBP2 AS A BIOMARKER FOR RENAL DYSFUNCTION
#2509Two-pore channels as regulators of proliferation in cancer
#2510Compositions and methods for modulating dopamine neurotransmission
#2511Chimeric Polypeptides Useful in Proximal and Dynamic High-Throughput Screening Methods
#2512Wnt antagonists and methods of treatment and screening
#2513NOVEL MULTIDRUG RESISTANCE-ASSOCIATED POLYPEPTIDE
#2514ALBUMIN FUSION PROTEINS
#2515Antibody to peptide
#2516C-Met receptor regulation by angiotensin IV (AT4) receptor ligands
#2517WISE/SOST NUCLEIC ACID SEQUENCES AND AMINO ACID SEQUENCES
#2518Muteins of tear lipocalin and methods for obtaining the same
#2519ISOLATION AND/OR PRESERVATION OF DENDRITIC CELLS FOR PROSTATE CANCER IMMUNOTHERAPY
#2520Inhibition of AXL signaling in anti-metastatic therapy
#2521Mammalian alpha-kinase proteins, nucleic acids and diagnostic and therapeutic uses thereof
#2522METHODS AND COMPOSITION TO ENHANCE PRODUCTION OF FULLY FUNCTIONAL P-GLYCOPROTEIN IN PICHIA PASTORIS
#2523COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR
#2524Methods of screening T1R1/T1R3 heteromeric receptors for compounds that modulate umami taste signaling
#2525FGFR extracellular domain acidic region muteins
#2526Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy
#2527Pathogen restriction factors
#2528METHODS OF IDENTIFYING OBM MODULATORS
#2529Recombinant protein production in heterologous systems
#2530INHIBITION OF LEUKOCYTE ADHESION
#2531Variant activin receptor polypeptides and uses thereof
#2532Biological Pacemaker
#2533METHODS FOR DETECTION OF BOTULINUM NEUROTOXIN
#2534Functional enhancement of microorganisms to minimize production of acrylamide
#2535Multi-specific FAB fusion proteins and methods of use
#2536Plexin D1 as a target for tumor diagnosis and therapy
#2537Sweet taste receptor-expressing construct, cell body expressing the same, and utilization thereof
#2538TMEM22 peptides and vaccines including the same
#2539TREATMENT OF CACHEXIA
#2540Modulation of glucagon receptor expression
#2541RBP4 in insulin sensitivity/resistance, diabetes, and obesity
#2542Prospective Identification and Characterization of Breast Cancer Stem Cells
#2543Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
#2544METHODS AND COMPOSITIONS FOR TREATING OPHTHALMIC CONDITIONS VIA SERUM RETINOL, SERUM RETINOL BINDING PROTEIN (RBP), AND/OR SERUM RETINOL-RBP MODULATION
#2545Sodium channel protein type III α-subunit splice variant
#2546Mutant Sodium Channel Nav1.7 and Methods Related Thereto
#2547Mutant smoothened and methods of using the same
#2548Smoothened polypeptides and methods of use
#2549IL4/IL13 binding repeat proteins and uses
#2550Isolation of a protein responsible for uranium (VI) reduction
#2551ORGANIC COMPOUNDS
#2552Isolation and use of ryanodine receptors
#2553METHODS FOR INHIBITING OCULAR ANGIOGENESIS
#2554Treatment of cancer
#2555STROMAL INTERACTING MOLECULE KNOCKOUT MOUSE AND USES THEREOF
#2556T1R taste receptors and genes encoding same
#2557HUMAN TRANSMEMBRANE PROTEINS
#2558Binding molecules for the treatment of myeloid cell malignancies
#2559HER3 binding polypeptides
#2560TRIM5alpha mutants and uses thereof
#2561Methods of using voltage-gated Hv1 proton channels to detect changes in intracellular pH
#2562DDR2 PROTEIN WITH ACTIVATED KINASE ACTIVITY AND PREPARATION METHOD THEREOF
#2563NOVEL GENES ENCODING PROTEINS HAVING PROGNOSTIC, DIAGNOSTIC, PREVENTIVE, THERAPEUTIC, AND OTHER USES
#2564METHODS AND COMPOSITIONS FOR MODULATING TWEAK AND FN14 ACTIVITY
#2565Method to generate antibodies to ion channels
#2566Broad spectrum ErbB ligand binding molecules and methods for preparing and using them
#2567Hemojuvelin fusion proteins
#2568Urate transporter, as well as method and kit for evaluating urate transport-related disease factor and inflammation-related disease factor, and test sample and drug
#2569ALBUMIN FUSION PROTEINS
#2570Water soluble membrane proteins and methods for the preparation and use thereof
#2571Transgenic mice expressing human toll-like receptor 8
#2572Dopaminergic neuron progenitor cell marker 187A5
#2573Methods and compositions for the treatment of immune disorders
#2574Treatment of liver disorders by administration of RAP conjugates
#2575Compounds, compositions and use
#2576Microorganisms for imaging and/or treatment of tumors
#2577DRUG SCREENING TARGET FOR ALZHEIMER'S DISEASE AND METHOD OF SCREENING POTENTIAL DRUGS
#2578GPCR fusion protein containing an N-terminal autonomously folding stable domain, and crystals of the same
#2579Methods for identifying inhibitors of botulinum neurotoxins
#2580Nucleic acids encoding a mut-T domain-containing polypeptide
#2581METHODS FOR TREATING NEURAL CELL SWELLING
#2582Method of improving transplant function using soluble complement receptor type I (sCR1)
#2583Method for producing proteins in that lack detectable cross binding activity to antibodies against host cell antigens
#2584CONSTRUCTS THAT ALLOW FOR DETECTION AND QUANTITATION OF MEMBRANE PROTEINS
#2585POLYPEPTIDES THAT BIND TISSUE INHIBITOR OF METALLOPROTEINASE TYPE THREE (TIMP-3), COMPOSITIONS AND METHODS
#2586Ox2 Receptor Homologs
#2587METHOD OF TREATING OR RETARDING THE DEVELOPMENT OF BLINDNESS
#2588Non-naturally occurring T cell receptors
#2589Composition comprising rna derived from lactic acid bacterium as effective component
#2590siRNA targeting catenin, Beat-1 (CTNNB1)
#2591Method and compositions for detecting botulinum neurotoxin
#2592Methods and materials for producing transgenic artiodactyls
#2593GPCR comprising an IC2 insertion
#2594MARKER FOR NEUROMYELITIS OPTICA
#2595GPCR Expressing Cell Lines and Antibodies
#2596Methods Relating to Peripheral Administration of Nogo Receptor Polypeptides
#2597Methods and compositions for diagnosis of ectopic pregnancy
#2598LIGHT-ACTIVATED ION CHANNEL MOLECULES AND USES THEREOF
#2599Liposome composition for targeting egfr receptor
#2600HUMAN PLATELET F11 RECEPTOR
#2601Viral vector encoding a toll-like receptor and encoding a toll-like receptor agonist
#2602Modified agrin-fragment capable of restoring muscle strength for use as a medicament
#2603SorCS1 for the treatment of obesity
#2604Methods of identifying candidate compounds of the human G protein-coupled receptor, GPR50, as modulators of body mass or adiposity
#2605METHODS AND COMPOSITIONS FOR TREATING OCCULAR DISORDERS
#2606EphA2 T cell epitopes and uses therefor
#2607Methods and compositions for modulating T cell and/or B cell activation
#2608METHODS AND PRODUCTS FOR MANIPULATING HEMATOPOIETIC STEM CELLS
#2609MUTANT LOW-DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN WITH INCREASED BINDING TO ALZHEIMER AMYLOID-BETA PEPTIDE
#2610METHODS AND COMPOSITIONS FOR IDENTIFYING MODULATORS OF ANTI-TETHERIN ACTIVITY TO INHIBIT PROPAGATION OF VIRUSES
#2611Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction
#2612Method for the production of antibodies that bind to multiple membrane spanning proteins
#2613TREATMENT OF COMPLEMENT-ASSOCIATED DISORDERS
#2614STIM2-MEDIATED CAPACITIVE CALCIUM ENTRY
#2615Taste receptors of the T1R family from domestic cat
#2616Taste receptors of the T1R family from domestic dog
#2617INOSITOL 1,4,5-TRIPHOSPHATE RECEPTOR-BINDING PROTEIN AND ITS NON-HUMAN TRANSGENIC MAMMALIAN ANIMALS
#2618Cloned transmembrane receptor for 24-hydroxylated vitamin D compounds and uses thereof
#2619Role of proteoglycans in drug dependence
#2620Detection of cells expressing T1R2 taste receptor
#2621Anti-PRO87299 Antibodies
#2622Rage fusion proteins and methods of use
#2623Method of predicting a behavior of one or more drugs
#2624Mutant proteins and methods for producing them
#2625NOVEL MEMBERS OF THE CAPSAICIN/VANILLOID RECEPTOR FAMILY OF PROTEINS AND USES THEREOF
#2626T1R taste receptors and genes encoding same
#2627Methods and compositions for obtaining and using biologically active multi-protein complexes
#2628MICROORGANISM FOR EXPRESSING A HUMAN MEMBRANE PROTEIN
#2629Methods for increasing adiponectin
#2630SorCS1-like agent for use in the treatment of insulin resistance and diseases related thereto
#2631Method for preparing recombinant glycoproteins with high sialic acid content
#2632TRP INHIBITORS AND USES THEREOF
#2633Monoclonal antibodies to dendritic cells
#2634Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
#2635Methods for identifying compounds that modulate sensory signaling through the taste cell specific G-protein coupled receptor GPCR-B4
#2636G protein coupled receptor protein and use thereof
#2637Albumin fusion proteins
#2638Albumin Fusion Proteins
#2639SiRNA targeting catenin, beta-1 (CTNNB1)
#2640Method and composition for crystallizing G protein-coupled receptors
#2641Inhibition of prion propagation by receptor associated protein (RAP), its derivatives, mimetics and synthetic peptides
#2642Monomeric and dimeric forms of adiponectin receptor fragments and methods of use
#2643Methods for identifying compounds which modulate T2R bitter taste receptors
#2644MER DIAGNOSTIC AND THERAPEUTIC AGENTS
#2645Method for in vivo expansion of T regulatory cells
#2646Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
#2647SYSTEMIC CARNITINE DEFICIENCY GENE AND USES THEREOF
#2648NOTCH Inhibition in the Treatment or Prevention of Atherosclerosis
#2649TENEURIN C-TERMINAL ASSOCIATED PEPTIDES (TCAP) AND METHODS AND USES THEREOF
#2650Pancreatic cancer targets and uses thereof
#2651Human Aadenosine receptor crystals and uses thereof
#2652Methods of reducing myocardial injury following myocardial infarction
#2653Signature Of Secreted Protein Isoforms Specific To Ovarian Cancer
#2654Engineered listeria and methods of use thereof
#2655MODIFIED EGFR ECTODOMAIN
#2656Expression of triple-helical collagen-like products in
#2657Peptide compositions that bind TLR-4
#2658Antagonist anti-Notch3 antibodies and their use in the prevention and treatment of Notch3-related diseases
#2659Production of defined monodisperse heparosan polymers and unnatural polymers with polysaccharide synthases
#2660PRRS-VIRUS RECEPTOR AND ITS INHIBITOR
#2661PEPTIDE-BASED REGULATION OF GAP JUNCTIONS
#2662Crystals of membrane proteins
#2663Interactive dental restorative network
#2664Methods of modulating cold sensory perception via a cold- and menthol-sensitive receptor (CMR1)
#2665MAMMALIAN CELL SURFACE ANTIGENS; RELATED REAGENTS
#2666Methods and composition for measuring the amount of Vitamin D derivatives
#2667E-cadherin as a biomarker of gastroesophageal reflux disease
#2668Molecular Interactions in Hematopoietic Cells
#2669NPC1L1 orthologues
#2670Neutral amino acid transporter and gene thereof
#2671COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES
#2672Prostate cancer diagnosis and treatment
#2673NPC1L1 (NPC3) AND METHODS OF USE THEREOF
#2674Methods for modulating neuronal responses
#2675USE OF A PROTEIN IN STEM CELL AND CANCER APPLICATIONS
#2676Use of IL-17 Polypeptides for Use in the Prevention or Treatment of Atherosclerosis
#2677Method of treating diabetes by administering an anti-NKp46 antibody
#2678Serpentine transmembrane antigens expressed in human cancers and uses thereof
#2679METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING PRURITIS
#2680Sulfation of Wnt pathway proteins
#2681Method For Detecting And Purifying Pancreatic Beta Cells
#2682METHODS AND COMPOSITIONS FOR MODULATING CARDIAC CONTRACTILITY
#2683Human LY6-Big Molecules and Methods of Use
#2684Use of modulators of compounds of TGF-β superfamily to regulate hepcidin-mediated iron metabolism
#2685Use of Guanylyl Cyclase C Agonists to Suppress Appetite
#2686PSCA: prostate stem cell antigen and uses thereof
#2687Method and kit for evaluation of predisposition to development of obesity, anti-obesity agent and method for screening thereof, non-human animal, adipose tissue, adipocyte, method for production of transgenic mouse, antigen, and antibody
#2688Non-functional P2Xreceptor
#2689METHODS RELATING TO PERIPHERAL ADMINISTRATION OF NOGO RECEPTOR POLYPEPTIDES
#2690Cancer-associated antigen
#2691Toll-like receptor-based biosensors
#2692METHODS OF DIAGNOSING CERVICAL CANCER
#2693Immunogenic epitopes of NGEP antigen
#2694INTERLEUKIN-13 RECEPTOR ALPHA 2 PEPTIDE-BASED BRAIN CANCER VACCINES
#2695Modulation of the Vps10p-domain receptor family for the treatment of mental and behavioural disorders
#2696Albumin fusion proteins
#2697NOVEL GENES ENCODING PROTEINS HAVING PROGNOSTIC, DIAGNOSTIC, PREVENTIVE, THERAPEUTIC, AND OTHER USES
#2698METHOD FOR INTRODUCING MUTANT GENE, GENE HAVING MUTATION INTRODUCED THEREIN, CASSETTE FOR INTRODUCING MUTATION, VECTOR FOR INTRODUCING MUTATION, AND KNOCK-IN NON-HUMAN MAMMALIAN ANIMAL
#2699System and method for monitoring and analyzing internet traffic
#2700Identification of novel antagonist toxins of T-type calcium channel for analgesic purposes